| Evaluation of polyphenolic profile and antibacterial activity of pomegranate juice in combination with rifampin (R) against MDR-TB clinical isolates M AlMatar, I Var, B Kayar, E Eker, E Kafkas, M Zarifikhosroshahi, F Köksal Current pharmaceutical biotechnology 20 (4), 317-326, 2019 | 17 | 2019 |
| The physiological/pathophysiological significance of vitamin d in cancer, cardiovascular disorders and beyond M AlMatar, H AlMandeal, E A Makky, B Kayar, E Yarar, I Var, F Koksal Current drug metabolism 18 (3), 207-224, 2017 | 8 | 2017 |
| Detection and Molecular Analysis of Moxifloxacin MIC Values of Mycobacterium tuberculosis Strains Isolated from Clinical Specimens T Bozok, B Kayar, G Yakıcı, E Eker, M Marzi, F Karslı, F Köksal Mikrobiyoloji Bulteni 53 (3), 245-253, 2019 | 2 | 2019 |
| Does the development of vaccines advance solutions for tuberculosis? M AlMatar, EA Makky, H AlMandeal, E Eker, B Kayar, I Var, F Köksal Current Molecular Pharmacology 12 (2), 83-104, 2019 | 1 | 2019 |
| DETECTION OF NDM-1-PRODUCING GRAM NEGATIVE BACTERIA FOR THE FIRST TIME IN SOUTHERN OF TURKEY F Heydari, TG Gokmen, S Kizilyildirim, E Yarar, F Koksal | | 2016 |
| DETECTION OF RIFAMPICIN AND ISONIAZIDE RESISTANCE INMYCOBACTERIUM TUBERCULOSIS WITH “MULTI-PCR-SSCP” METHOD IN CUKUROVA REGION, TURKEY B KAYAR, M MARZI, G YAKICI, E YARAR, F KOKSAL | | 2015 |
| RELATIONSHIP BETWEEN RPOB GENE MUTATIONS AND MIC OF RIFAMPICIN IN MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED IN CUKUROVA REGION, TURKEY B KAYAR, A ATILGAN, M MARZI, E YARAR, F KOKSAL | | 2015 |
